Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) has announced a definitive agreement to acquire Oak Street Health (NYSE: OSH) in an all-cash deal valued at approximately $10.6 billion, or $39 per share. This acquisition aims to enhance CVS's care delivery strategy, particularly for underserved communities, by leveraging Oak Street's innovative, value-based healthcare model. With over 169 medical centers across 21 states, Oak Street Health focuses on providing quality care for older adults. CVS anticipates significant synergies from the merger, projecting more than $500 million in long-term operating income growth and increased access to healthcare services.
Aetna Better Health of West Virginia has secured a new Medicaid managed care contract from the West Virginia Department of Health and Human Resources to continue serving Mountain Health Promise members. The contract, effective July 1, 2023, will support around 30,000 beneficiaries, providing physical and behavioral health care services, particularly for children in foster care and those receiving adoption assistance. Aetna has invested $6.1 million and $9.3 million to enhance community-based services, aiding in the transition of children from residential facilities. This contract potentially includes three one-year extensions.
CVS Health® (NYSE: CVS) has launched the CVS Health Community Equity Alliance to enhance health access in underserved communities across the U.S. This initiative aims to expand the community health worker workforce, improve connections between healthcare institutions and communities, and address health disparities, particularly in heart and mental health. Initial partners include Meharry Medical College, Sinai Chicago, and Wayne State University. Funding will be provided for tailored initiatives, and the Alliance will promote evidence-based interventions to make healthcare more accessible.
CVS Health has appointed David Joyner as Executive Vice President and President of Pharmacy Services, effective January 30, 2023, and Amy Bricker as Executive Vice President and Chief Product Officer – Consumer, starting in February. Joyner returns to lead the Pharmacy Services segment, overseeing solutions for over 110 million members through CVS Caremark and CVS Specialty, while Bricker will focus on consumer product innovation to meet evolving healthcare needs. The changes come as Dr. Alan Lotvin, the former head of Pharmacy Services, plans his retirement in April after a decade with the company.
CVS Health has announced a new collaboration with RUSH University System for Health to enhance healthcare access for Medicare patients in Chicago. This partnership focuses on coordinated care based on Medicare's ACO REACH model, promoting health equity and reducing unnecessary medical costs. Patients can access RUSH clinical services through ACO REACH-participating MinuteClinics in Chicago and Evanston, which provide in-person and virtual care. The initiative aims to bolster care coordination and support for 35,000 Medicare beneficiaries, ensuring comprehensive services including transportation and cost-sharing assistance. This agreement underscores CVS's commitment to improving health equity.
CVS Health (NYSE: CVS) will conduct a conference call on February 8, 2023, at 8:00 a.m. ET to discuss its fourth quarter and full-year 2022 financial results. The call aims to provide insights into the company’s performance over the past year. Investors and analysts can participate via an audio webcast available on the CVS Health Investor Relations website, where it will remain archived for one year.
CVS Health (NYSE: CVS) announced the appointment of Sam Khichi as Executive Vice President, Chief Policy Officer, and General Counsel, effective February 13, 2023. In this role, he will oversee the legal, compliance, and government affairs teams, aiming to enhance healthcare accessibility and affordability. Khichi, with extensive experience in managing healthcare legal strategies, succeeds Tom Moriarty, who is retiring in April 2023. CVS Health's President and CEO, Karen S. Lynch, praised Khichi's track record in leading significant transformations in healthcare organizations.
CVS Health (NYSE: CVS) announced that President and CEO Karen S. Lynch and Executive Vice President and CFO Shawn Guertin will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 8:15 a.m. Pacific Time. An audio webcast of the presentation will be available on the Investor Relations section of the CVS Health website, archived for one year.
CVS Health is a leading health solutions company dedicated to improving community health through local presence and digital channels.
CVS Health has approved a quarterly dividend of $0.605 per share, reflecting a 10% increase from the previous dividend. The dividend will be paid on February 1, 2023, to shareholders on record by January 20, 2023. This decision indicates the company's ongoing commitment to returning value to its shareholders amidst its expanding role in healthcare.
Aetna Better Health of West Virginia, a CVS Health company, has allocated $6.1 million to 18 healthcare providers in West Virginia. This funding aims to enhance community-based waiver services for children with serious emotional disorders (CSED) and support their transition from residential facilities to home or community settings. The initiative supports over 500 children in state facilities, focusing on intensive behavioral health services. Aetna’s investment will facilitate hiring staff, training, and developing specialized programs to improve mental health outcomes for youth.